BlackRock’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-225,727
| Closed | -$19.5K | – | 5430 |
|
|
2023
Q3 | $19.5K | Sell |
225,727
-6,114
| -3% | -$530 | ﹤0.01% | 5080 |
|
|
2023
Q2 | $130K | Buy |
231,841
+18,304
| +9% | +$10.3K | ﹤0.01% | 4754 |
|
|
2023
Q1 | $243K | Buy |
213,537
+10,895
| +5% | +$12.4K | ﹤0.01% | 4639 |
|
|
2022
Q4 | $227K | Buy |
202,642
+1,223
| +0.6% | +$1.37K | ﹤0.01% | 4732 |
|
|
2022
Q3 | $423K | Sell |
201,419
-5,759
| -3% | -$12.1K | ﹤0.01% | 4683 |
|
|
2022
Q2 | $282K | Sell |
207,178
-5,009
| -2% | -$6.82K | ﹤0.01% | 4852 |
|
|
2022
Q1 | $358K | Buy |
212,187
+54,315
| +34% | +$91.6K | ﹤0.01% | 4872 |
|
|
2021
Q4 | $172K | Sell |
157,872
-12,630
| -7% | -$13.8K | ﹤0.01% | 5066 |
|
|
2021
Q3 | $503K | Buy |
170,502
+3,252
| +2% | +$9.59K | ﹤0.01% | 4685 |
|
|
2021
Q2 | $503K | Sell |
167,250
-1,150,685
| -87% | -$3.46M | ﹤0.01% | 4625 |
|
|
2021
Q1 | $4.3M | Sell |
1,317,935
-2,249
| -0.2% | -$7.33K | ﹤0.01% | 3946 |
|
|
2020
Q4 | $5.44M | Sell |
1,320,184
-21,115
| -2% | -$87K | ﹤0.01% | 3599 |
|
|
2020
Q3 | $7.26M | Sell |
1,341,299
-47,624
| -3% | -$258K | ﹤0.01% | 3317 |
|
|
2020
Q2 | $9.35M | Buy |
1,388,923
+261,086
| +23% | +$1.76M | ﹤0.01% | 3154 |
|
|
2020
Q1 | $3.59M | Buy |
1,127,837
+48,311
| +4% | +$154K | ﹤0.01% | 3416 |
|
|
2019
Q4 | $7.55M | Buy |
1,079,526
+605,048
| +128% | +$4.23M | ﹤0.01% | 3333 |
|
|
2019
Q3 | $1.82M | Buy |
474,478
+34,267
| +8% | +$132K | ﹤0.01% | 3733 |
|
|
2019
Q2 | $1.67M | Sell |
440,211
-18,001
| -4% | -$68.5K | ﹤0.01% | 3783 |
|
|
2019
Q1 | $1.65M | Sell |
458,212
-16,867
| -4% | -$60.7K | ﹤0.01% | 3728 |
|
|
2018
Q4 | $3.68M | Buy |
+475,079
| New | +$3.68M | ﹤0.01% | 3461 |
|